Dapagliflozin improves renal injury in diabetic nephropathy rats

doi:10.12307/2022.226

Abstract

Abstract: BACKGROUND: Dapagliflozin has obvious renal protective effect on renal injury caused by diabetic nephropathy.
OBJECTIVE: To explore the possible mechanism by which dapagliflozin can improve renal injury in diabetic nephropathy rats through microRNA-126.
METHODS: Sprague-Dawley rat models of diabetic nephropathy were successfully established, and randomly divided into a model group, a metformin group and a dapagliflozin group, with six rats in each group. They were given the same dose of normal saline, metformin (500 mg/kg) and dapagliflozin (10 mg/kg) by gavage once a day. Another six rats with normal diet were selected as control group. Twelve weeks later, the rats in each group were killed under anesthesia. Fasting blood glucose, serum creatinine, urea nitrogen and 24-hour urinary microalbumin levels were detected. The level of microRNA-126 in rat kidney was detected by qRT-PCR. The levels of transforming growth factor-β 1, vascular endothelial growth factor receptor 2 and phosphate and tension homology deleted on chromosome ten (PTEN) in rat kidney were detected by qRT-PCR, western blot and immunohistochemistry. The ultrastructural and pathological changes of the rat kidney were observed by electron microscope, hematoxylin-eosin staining and Masson staining.
RESULTS AND CONCLUSION: The levels of fasting blood glucose, serum creatinine, urea nitrogen, 24-hour urinary microalbumin, transforming growth factor-β1, and vascular endothelial growth factor receptor 2 in the model group were significantly higher than those in the normal group (P < 0.05), and the levels of microRNA-126 and PTEN were significantly lower than those in the normal group. The levels of fasting blood glucose, serum creatinine, urea nitrogen, 24-hour urinary microalbumin, transforming growth factor-β 1, and vascular endothelial growth factor receptor 2 in the metformin group and dapagliflozin group were significantly lower than those in the model group (P < 0.05), and the levels of microRNA-126 and PTEN were significantly higher than those in the model group. The above changes were more significant in the dapagliflozin group compared with the metformin group (P < 0.05). Renal histopathological findings indicated that compared with the model group, the renal lesions in the metformin group and the dapagliflozin group was milder, the foot process of the dapagliflozin group was better than that of the metformin group, and the renal morphology was relatively normal in the dapagliflozin group. These findings indicate that dapagliflozin can up-regulate the level of microRNA-126, inhibit the expression of transforming growth factor-β 1, and vascular endothelial growth factor receptor 2, promote the expression of PTEN, and delay the process of renal injury in diabetic nephropathy rats.

Key words: diabetic nephropathy, dapagliflozin, kidney, microRNA-126, transforming growth factor-β1, vascular endothelial growth factor receptor 2, phosphate and tension homology deleted on chromosome ten

CLC Number:

Wang Qin, Shen Cheng, Liao Jing, Yang Ye. Dapagliflozin improves renal injury in diabetic nephropathy rats[J]. Chinese Journal of Tissue Engineering Research, 2022, 26(8): 1216-1222.

Figures/Tables 8

References

[1] WU JX, JIA A, TAN YF, et al. Effect of Alpina oxyphylla extract on streptozotocin-induced kidney injure via regulating TGF-β1 and MyD88. BMC Complement Med Ther. 2020;20:217.
[2] DESIRÉE LR, ALBERTO MC, JOSÉ LG, et al. Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy. World J Diabetes. 2012;3(1):7-18.
[3] MAMDOUH A, MOHAMMED F, MARWA M, et al. Dapagliflozin attenuates early markers of diabetic nephropathy in fructose-streptozotocin-induced diabetes in rats. Biomed Pharmacother. 2019; 109:910-920.
[4] WANNER C, INZUCCHI SE, LACHIN JM, et al. Empagliflozin and progressionof kidney disease in type 2 diabetes. N Engl J Med. 2016; 375:323-334.
[5] 祝再然,张明,赵桂金,等. SGLT2 抑制剂对糖尿病肾病大鼠足细胞损伤及PTEN/PI3K/Akt 信号通路的影响[J]. 广东医学,2020,41(24): 2490-2494.
[6] BHATT K, MI QS, DONG Z. MicroRNAs in kidneys: biogenesis, regulation, and pathophysiological roles. Am J Physiol. 2011;300(3):F602-610.
[7] SUN T, LIU Y, LIU L, et al. MicroRNA-544 attenuates diabetic renal injury via suppressing glomerulosclerosis and inflammation by targeting FASN. Gene. 2020;723:143986.
[8] FENG Y, JIN MY, LIU DW, et al. Correction: Proteasome subunit-alpha type-6 protein is post-transcriptionally repressed by the microRNA-4490 in diabetic nephropathy. Biosci Rep. 2019;1:39.
[9] WANG S, AURORA AB, JOHNSON BA, et al. The endo-thelial-specific microRNA miR-126 governs vascular integrityand angiogenesis. Dev Cell. 2008;15:261-271.
[10] GHADA AK, GHAZI AM, HALFA ABDULLA AM, et al. Decreased expression of circulating microRNA-126 in patients with type 2 diabetic nephropathy: A potential blood-based biomarker. Exp Ther Med. 2016; 12:815-822.
[11] SUN F, YU PF, WANG D, et al. MicroRNA-488 regulates diabeticnephropathy via TGF-β1 pathway. Eur Rev Med Pharmacol Sci. 2019;23:4333-4340.
[12] LAVOZ C, RODRIGUES-DIEZ R, ANITA PLAZA A, et al. VEGFR2 Blockade Improves Renal Damage in an Experimental Model of Type 2 Diabetic Nephropathy. J Clin Med. 2020;9:302.
[13] YUAN Y, SHEN C, ZHAO SL, et al. MicroRNA-126 affects cell apoptosis, proliferation, cell cycle and modulates VEGF/TGF-β levels in pulmonary artery endothelial cells. Eur Rev Med Pharmacol Sci. 2019;23: 3058-3069.
[14] LI YJ, HU QS, LI CL, et al. PTEN-induced partial epithelial-mesenchymal transition drives diabetic kidney disease. J Clin Invest. 2019;129(3):1129-1151.
[15] GE R, LV YT, LI PP, et al. Upregulated microRNA-126 induces apoptosis of dental pulp stem cell via mediating PTEN-regulated Akt activation. J Clin Lab Anal. 2021;35:e23624.
[16] CHEN SR, CAI WP, DAI XJ, et al. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways. Eur Rev Med Pharmacol Sci. 2019;23:3461-3470.
[17] 章江南. 达格列净对早期 2 型糖尿病肾病临床效果及尿微量白蛋白的影响[J].北方药学,2020,17(6):8-9.
[18] HATANAKA T, OGAWA D, TACHIBANA H, et al. Inhibition of SGLT2 alleviates diabetic nephropathy by suppressing high glucose‐induced oxidative stress in type 1 diabetic mice. Pharmacol. Res Perspect. 2016; 4:e00239.
[19] ISHIBASHI Y, MATSUI T, YAMAGISHI S. Tofogliflozin, a highly selective inhibitor of SGLT2 blocks proinflammatory and proapoptotic effects of glucose overload on proximal tubular cells partly by suppressing oxidative stress generation. Horm Metab Res. 2016;48:191-195.
[20] VJERA N, TEA O, HRVOJE R, et al. Renal Benefits of SGLT 2 Inhibitors and GLP-1Receptor Agonists: Evidence Supporting a Paradigm Shift in the Medical Management of Type 2 Diabetes. Int J Mol Sci. 2019;20:5831.
[21] PAPAIT R, SERIO S, PAGIATAKIS C, et al. Histone methyltransferase G9a is required for cardiomyocyte homeostasis and hypertrophy. Circulation. 2017;136:33-34.
[22] TOMASETTI M, NOCCHI L, STAFFOLANI S, et al. MicroRNA-126 suppresses mesothelioma malignancy by targeting IRs1 and interfering with the mitochondrial function. Antioxid Redox Signal. 2014;21(15):2109-2125.
[23] 崇显瑾, 余青原, 杨历新. 2 型糖尿病肾病患者血清中 miR-126 和 sVCAM-1 的表达关系及意义[J]. 河北医药,2019,41(3):334-342.
[24] HU Z, WONG KW, ZHAO HM, et al. Sendai virus mucosal vaccination establishes lung-resident memory CD8 T cell immunity and boosts BCG-Primed protection against TB in mice. Mol Ther J Am Soc Gene Ther. 2017;25:1222-1233.
[25] 郭晓莉, 陈艳, 马卫国.等. 血液循环中 miR-126 作为标志物对 2 型糖尿病肾脏疾病患者诊断的临床意义[J]. 临床肾脏病杂志,2017, 17(6):361-365.
[26] JAMES V, PAUL H, MATTHEW S, et al. Anti–TGF-b1 Antibody Therapy in Patients with Diabetic Nephropathy. J Am Soc Nephrol. 2017;28: 953-962.
[27] JIN J, CHAO PENG C, WU SZ, et al. Blocking VEGF/Caveolin-1 signaling contributes to renal protection of fasudil in streptozotocin-induced diabetic rats. Acta Pharmacologica Sinica. 2015;36:831-840.
[28] YU SJ, ZHAO HR, YANG WJ, et al. The Alcohol Extract of Coreopsis tinctoria Nutt Ameliorates Diabetes and Diabetic Nephropathy in db/db Mice through miR-192/miR-200b and PTEN/AKT and ZEB2/ECM Pathways. BioMed Res Int. 2019;2019:5280514.
[29] CHEN KH, DAI HZ, YUAN JJ, et al. Optineurin-mediated mitophagy protects renal tubular epithelial cells against accelerated senescence in diabetic nephropathy. Cell Death Dis. 2018;9:105.
[30] MAHMOUDI RM, MAHMOUDI RN, MIRDAMADI Y. Expression of TGF-beta3 in isolated fibroblasts from foreskin. Rep Biochem Mol Biol. 2015;3:76-81.
[31] DING JN, WANG X, CHEN B, et al. Exosomes Derived from Human Bone Marrow Mesenchymal Stem Cells Stimulated by Deferoxamine Accelerate Cutaneous Wound Healing by Promoting Angiogenesis. BioMed Res Int. 2019;2019:9742765.